EndoTODAY | EndoATLAS | Outpatient Clinic

Parasite | Esophagus | Stomach | Cancer | ESD

Home | Guide | Author | Subscription | Links


[Á¦66ȸ ³»½Ã°æÇÐȸ Ãß°èÇмú´ëȸ]

ÀϽÃ: 2016³â 11¿ù 26ÀÏ

Àå¼Ò: ¼­¿ï È«Àºµ¿ ±×·£µå ÈúÆ° È£ÅÚ

óÀ½À¸·Î Æ÷½ºÅÍ ±¸¿¬À» ½ÃµµÇÏ¿´´Âµ¥ ¹ÝÀÀÀÌ ÁÁ¾Ò½À´Ï´Ù.


1. »õ·Î¿î ½Ã´ëÀÇ »õ·Î¿î ³»½Ã°æ ±³À° (ÀÌÁØÇà)

¾Æħ ÀÏÂï Âü¼®ÇØÁֽŠ¿©·¯ºÐ²² °¨»çµå¸³´Ï´Ù.

Åä·ÐÀ» Çϸ鼭 ¸¹Àº »ý°¢ÀÌ µé¾ú½À´Ï´Ù. ¸Â½À´Ï´Ù. ÀÚÀ²ÇнÀÀÌ °¡Àå ÁÁÀº °øºÎ ¹æ¹ýÀÔ´Ï´Ù. ±×·¯³ª È¥ÀÚ °øºÎÇÒ ½Ã°£À» °®±â ¾î·Á¿î ȯ°æµµ ÀÖÀ» °ÍÀÌ°í, technical tipÀÌ Áß¿äÇÑ ¿µ¿ª¿¡¼­´Â ÀÚÀ²ÇнÀÀÌ È¿°úÀûÀÌÁö ¸øÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ÀûÀýÇÑ Áöµµ ¾øÀÌ´Â Àß ¸ø ¹è¿ï ¼öµµ ÀÖ½À´Ï´Ù. ±×·¡¼­ Àú´Â °øºÎÇÏ°íÀÚ ÇÏ´Â ÀÇ¿åÀÌ ÀÖ´Â »ç¶÷¿¡°Ô´Â ´Ü±â ÁýÁß ÁÖÀÔ½Ä ±³À°ÀÌ ¸Å¿ì È¿°úÀûÀ̶ó´Â »ý°¢À¸·Î °£°áÇÏ°í ½ÇÁ¦ÀûÀΠǥÁØ ±³À° ÇÁ·Î±×·¥ °³¹ß°ú º¸±ÞÀ» ÁÖâÇÏ°í ÀÖ´Â °ÍÀÔ´Ï´Ù.

ÀúÈñ ÆÀ¿¡¼­´Â 2016³â 11¿ù ÇöÀç ¾Æ·¡¿Í °°Àº Ç¥ÁØ ÇÁ·Î±×·¥À» °®°í ÀÖ½À´Ï´Ù. ´õ¿í ¹ßÀü½ÃÄѺ¼ °èȹÀÔ´Ï´Ù.

 ±³À° ÇÁ·Î±×·¥ (2016³â 11¿ù ÇöÀç)

 1) Starting endoscopy

 2) Basic VODs

 3) Manual (quick reference)

 4) How to describe

 5) Classification

 6) One point lession

 7) SMC 3 months course

 8) SMC endoscopy quiz

 9) SMC Endoscopy Unit

 
 2016/17 Basic Endoscopy Course 


2. Stretta procedure (¾Æ»êº´¿ø Á¤ÈÆ¿ë)

"Stretta Ä¡·á´Â gap Ä¡·áÀÔ´Ï´Ù."

1) ³»°úÀû Ä¡·á¿Í ¿Ü°úÀû Ä¡·áÀÇ gap¿¡ ÇØ´çÇÏ´Â Ä¡·áÀÔ´Ï´Ù. ´ëºÎºÐÀÇ È¯ÀÚ¿¡°Ô ÇØ´çÇÑ´Ù¸é gapÀ̶ó°í ÇÒ ¼ö ¾øÀ» °ÍÀÔ´Ï´Ù. 10-15% Á¤µµÀÇ È¯ÀÚ¿¡°Ô Àû¿ëÇÒ ¼ö ÀÖ´Â gap Ä¡·áÀÔ´Ï´Ù.

2) Gap Ä¡·á·Îµµ È¿°ú°¡ ¾øÀ¸¸é ¼ö¼ú·Î ³Ñ¾î°¡¾ß ÇÕ´Ï´Ù. ¼ö¼ú·Î ³Ñ¾î°¡±â¿¡ À¯¸®ÇÑ Ä¡·á°¡ StrettaÀÔ´Ï´Ù.

Stretta procedure for bariatric patient: Sleeve gastrectomy¸¦ ¹ÞÀº ȯÀÚ¿¡¼­´Â À§¿ëÀûÀÌ Àû¾î¼­ GERD°¡ ¹ß»ýÇϱ⠽¬¿îµ¥ ÀÌ È¯ÀÚ¿¡¼­´Â fundoplicationÀ» ÇÒ ¼ö ¾ø°í Stretta¸¦ Àû¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

Poor outcomeÀÌ ¿¹ÃøµÇ´Â ȯÀÚ
Subjects under the age of 18 (¾Æ¸¶µµ µ¿ÀǼ­ ¹®Á¦)
Pregnant women
Patients without a diagnosis of GERD
Hiatal hernia > 2 cm
Achalasia
Poor surgical candidates

¾Æ»êº´¿ø Stretta ½Ã¼ú 10¿¹ Áß 6¸íÀº PPI¸¦ ²÷¾ú´Ù°í ÇÕ´Ï´Ù. Stretta ½Ã¼ú ÈÄ LES pressure°¡ 10 ÀÌ»óÀ¸·Î ¿Ã¶ó°©´Ï´Ù. 10 ¹Ì¸¸ÀÎ »ç¶÷Àº 10 ÀÌ»óÀ¸·Î ¿Ã¶ó°¡´Âµ¥ 20 Á¤µµÀÎ »ç¶÷ÀÌ ´õ ÀÌ»ó ¿Ã¶ó°¡Áö´Â ¾Ê½À´Ï´Ù.

Anxiety, overlap syndromeÀÌ ÀÖ´Â »ç¶÷Àº ¿ª·ù Áõ»óÀº ÁÁ¾ÆÁöÁö¸¸ anxiety³ª ´Ù¸¥ Áõ»ó ¶§¹®¿¡ overall quality of life´Â °³¼±µÇÁö ¾Ê½À´Ï´Ù.


[Floor Áú¹®] »çÀü Æò°¡´Â ¾î¶»°Ô ÇϽʴϱî?

[Á¤ÈÆ¿ë ±³¼ö´Ô ´äº¯] ³»½Ã°æ°ú manometry Á¤µµ¸¦ ÇÏ°í ÀÖ½À´Ï´Ù. ³»½Ã°æ¿¡¼­ hiatal hernia°¡ º¸ÀÌ¸é ½Ã¼úÇÏÁö ¾Ê´Â °ÍÀÌ ÁÁ½À´Ï´Ù. LES pressure°¡ 10ÀÌÇÏ·Î ³·Àº »ç¶÷ÀÌ ¸¹Áö´Â ¾ÊÁö¸¸ À̵鿡¼­´Â È¿°ú°¡ ´õ ÁÁÀ» °Í °°½À´Ï´Ù.

[Floor Áú¹®] ºñ¿ëÀº ¾î¶»½À´Ï±î?

[Á¤ÈÆ¿ë ±³¼ö´Ô ´äº¯] ½ÅÀÇ·á±â¼ú ½ÅûÀ» Çϸé NECA¿¡¼­ systemic review¸¦ ÇÑ ÈÄ »ç¿ë °¡´ÉÀ¸·Î ÆÇÁ¤ÀÌ µÇ¸é 1³â ÈÄ ½ÉÆò¿ø ÇÁ·Î¼¼½º¸¦ ÁøÇàÇÏ°Ô µÇ¾î ÀÖ½À´Ï´Ù. ±×·±µ¥ ¾ÆÁ÷µµ 1³â ÈÄ ½Ã¼ú ¼ºÀûÀ» Æò°¡ÇÏ´Â ÀÛ¾÷ÀÌ Àß µÇÁö ¾Ê°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ÇöÀç´Â ½Ç¼Õº¸ÇèÀ» ¹ÞÀ» ¼öµµ ¾ø½À´Ï´Ù. Catheter °¡°ÝÀº 5000 ´Þ·¯ Á¤µµÀÔ´Ï´Ù. ȯÀÚ´Â 600¸¸¿ø Á¤µµ¸¦ ³»°Ô µË´Ï´Ù.

[Floor Áú¹®] ÃÖ±ÙÀÇ meta-analysis¿¡¼­ Áõ»óÀ̳ª parameter µî¿¡¼­ È¿°ú°¡ ¾ø´Ù´Â °á·ÐÀ̾ú´Âµ¥¿ä... ¾î¶»°Ô »ý°¢ÇϽôÂÁö¿ä?

[Á¤ÈÆ¿ë ±³¼ö´Ô ´äº¯] ¸ðµç parameter°¡ ´Ù ÁÁ¾ÆÁö´Â °ÍÀº ¾Æ´Õ´Ï´Ù. ±×·¯³ª ÀϺΠparameter¿Í »ó´ç¼ö Áõ»óÀÌ °³¼±µË´Ï´Ù. ¼ö¼ú·Î PPI¸¦ ²÷À» ¼ö ÀÖ´Â °æ¿ì´Â 60-70% Á¤µµÀÔ´Ï´Ù. Gap Ä¡·áÀÎ Stretta°¡ À̺¸´Ù ³ôÀ» °ÍÀ¸·Î ±â´ëÇϱâ´Â ¾î·Æ½À´Ï´Ù. ȯÀÚÀÇ Áõ»óÀº ÁÁ¾ÆÁöÁö¸¸ ÀϹÝÀûÀÌ°í °´°üÀûÀÎ parameter°¡ ¶Ñ·ÇÇÏ°Ô ÁÁ¾ÆÁö´Â °ÍÀº ¾Æ´Õ´Ï´Ù.

* Âü°í: EndoTODAY Stretta procedure


3. »óºÎÀ§Àå°ü ½ÉÆ÷Áö¾ö

1) Endoscopic gastric cancer screening - comparison with Japanese guideline (¿¬¼¼´ëÇб³ ÀÌ»ó±æ)

ÀϺ»¿¡¼­ À§³»½Ã°æÀÇ ÃÑ ³ëµ¿½Ã°£À» 74ºÐÀ¸·Î ¼³¸íÇÏ°í ÀÖ½À´Ï´Ù. ÀÇ»ç´Â 11ºÐÀÔ´Ï´Ù.

ÀÌÁØÇà È¥ÀÚ »ý°¢: ÀϺ»°ú ¿ì¸®³ª¶ó´Â ´Þ¶óµµ ³Ê¹« ´Ù¸£´Ù´Â °ÍÀ» ´Ù½Ã Çѹø ´À³¢´Â °­ÀÇ¿´½À´Ï´Ù.


2) Endoscopy after surgical or endoscopic treatment of gastric cancer (±¹¸³¾Ï¼¾ÅÍ Á¶¼öÁ¤)

ÀÌÁØÇà È¥À㸻: ÀÏÀü¿¡ ÀϺ» ±¹¸³¾Ï¼¾ÅÍÀÇ metachronous cancer¿¡ ´ëÇÑ ÀÚ·á°¡ EndoscopyÁö¿¡ ¹ßÇ¥µÈ ÀûÀÌ ÀÖ½À´Ï´Ù (Abe S. Endoscopy 2015 Dec). ÀÌ ³í¹®¿¡ ´ëÇÏ¿© ¼­¾ç »ç¶÷ (Imperiale µî)ÀÌ editorialÀ» ºÙ¿´´Âµ¥ ¿ÂÅë overdiagnosis issueÀÔ´Ï´Ù (Imperiale. Endoscopy 2015 Dec). °üÁ¡ÀÌ Âü ¸¹ÀÌ ´Ù¸£´Ù°í »ý°¢µË´Ï´Ù.

Imperiale. Endoscopy 2015 Dec

ÀÌÁØÇà comment: "ÀúÈñ ±â°ü¿¡¼­ Á¶±âÀ§¾Ï ³»½Ã°æ Ä¡·á ÈÄ metachronous cancer´Â ¸Å³â 1% Á¤µµ ¹ß°ßµÇ°í ÀÖ½À´Ï´Ù. ESD·Î ÇØ°áÇÒ ¼ö ÀÖ´Â °æ¿ì´Â ¾à 70%ÀÌ°í ¼ö¼úÀÌ ÇÊ¿äÇÑ °æ¿ì´Â ¾à 30%ÀÔ´Ï´Ù. 2015³â ¸» ÀϺ» µ¿°æ¾Ï¼¾ÅÍ¿¡¼­ ESD ÈÄ metachronous cancer¿¡ ´ëÇÑ ³í¹®À» ½Ç¾ú´Âµ¥ editorial¿¡¼­´Â over-diagnosis¿Í over-surveillance¿¡ ´ëÇÑ °ÆÁ¤À¸·Î °¡µæ ä¿öÁ® ÀÖ¾ú½À´Ï´Ù. ƯÈ÷ °í·É ȯÀÚ°¡ ¹®Á¦Àä... ±¹°¡ ¾Ï°ËÁø¿¡¼­ 75¼¼ ÀÌÈÄ¿¡´Â surveillance endoscopy¸¦ Áß´ÜÇϵµ·Ï ±Ç°íÇÏ°í Àִµ¥¿ä, Á¶±âÀ§¾Ï ³»½Ã°æ Ä¡·á ÈÄ¿¡µµ age upper limit¸¦ ¼±Á¤ÇÒ ÇÊ¿ä´Â ¾øÀ»Áö Áú¹®µå¸³´Ï´Ù."

* Âü°í: EndoTODAY metachronous cancer after ESD

* Âü°í: EndoTODAY ÀÜÀ§¾Ï

* Âü°í: EndoTODAY subtotal gastrectomy ÈÄ ÃßÀû°üÂû


3) Endoscopic findings of early gastric cancer - one more step (ºÎ»ê´ëÇб³ ±è±¤ÇÏ)

ºÐÈ­Çü ¾ÏÀº ¾Ï¼¼Æ÷°¡ Áõ°¡Çϸ鼭 Ç÷°üµµ Áõ°¡Çϴµ¥, ¹ÌºÐÈ­Çü ¾ÏÀº ¾Ï¼¼Æ÷°¡ Áõ°¡Çصµ Ç÷°üÀÌ Áõ°¡ÇÏÁö ¾Ê±â ¶§¹®¿¡ ¹ÌºÐÈ­Çü ¾ÏÀº Åð»öÇüÀ¸·Î º¸ÀÌ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù.

Peristalsis¿¡ µû¶ó ¸ð¾çÀÌ ´Ù¸£¸é Á¡¸·¾ÏÀÏ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

IIcÇüÀº 'ulcer°¡ ¾ø´Â IIcÇü'°ú 'ulcer°¡ ÀÖ´Â IIcÇü'À¸·Î ³ª´©¾î »ý°¢ÇÒ ¼ö ÀÖ½À´Ï´Ù.

À§°¢, ÀüÁ¤ºÎ, üºÎ ´ë¸¸ÀÇ ÇÔ¸ôÇü º´¼Ò´Â ½É´Þµµ¸¦ ±í°Ô º¸´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. üºÎ ´ë¸¸¿¡¼­´Â ÁÖ¸§ÀÇ ÁýÁß»óÀ» °­Á¶ÇØ º¸´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ¼Û±â·®À» ÃæºÐÈ÷ ÇÏ¿© ´ë¸¸ÀÇ ÁÖ¸§À» ÃæºÐ½Ã ½ÅÀü½ÃŲ ÈÄ ÇÔ¸ôºÎÀÇ ±íÀÌ¿Í ÇÔ¿ä¸éÀÇ ¼º»ó, ÁÖ¸§ÀÇ ÁýÁß»óÀ» Æò°¡ÇØ¾ß ÇÕ´Ï´Ù.


4) Indications of endoscopic treatment of EGC (°¡Å縯´ëÇб³ Á¤´ë¿µ)

Á¤´ë¿µ ±³¼ö´ÔÀº Á¦°¡ ºÐ¼®ÇÑ ÀڷḦ »ó¼¼È÷ ¼Ò°³ÇØ Áּ̽À´Ï´Ù (Lee JH. Surg Endosc 2016). °¨»çÇÕ´Ï´Ù. ù ÀúÀÚ Lee JHÀº ÀÌÁØÇàÀÌ ¾Æ´Ï°í ÀÌÁØÈñÀÔ´Ï´Ù. First author (Lee JH, ÀÌÁØÈñ)¿Í corresponding author (Lee JH, ÀÌÁØÇà)ÀÇ ¿µ¾î ¾àÀÚ°¡ µ¿ÀÏÇÑ ÈñÇÑÇÑ °æ¿ìÀÔ´Ï´Ù. ^^

ÀüüÀûÀ¸·Î 6.9% (141/2,041)°¡ down-grade µÇ°í 15.9% (324/2,041)°¡ up-grade µÇ¾ú½À´Ï´Ù. Diagnostic group classificationÀÌ ±×·¸°Ô ¹Ù²î¾ú´Ù´Â ÀǹÌÀÔ´Ï´Ù.

ÀÌÁØÇà comment (ÁغñÇÏ¿´À¸³ª ÃÑȸ¶§¹®¿¡ ½ÇÁ¦·Î ¹ß¾ðÇÏÁö´Â ¸øÇß½À´Ï´Ù) : "³»½Ã°æÀ¸·Î ¿ÏÀüÀýÁ¦µÈ È®´ëÀûÀÀÁõ Á¶±âÀ§¾ÏÀÇ Àå±â ¼ºÀûÀº ¾çÈ£ÇÕ´Ï´Ù. ±×·¯³ª ¿ªÀº ¼º¸³ÇÏÁö ¾Ê½À´Ï´Ù. È®´ëÀûÀÀÁõÀ» ³»½Ã°æÀ¸·Î ¿ÏÀüÀýÁ¦ÇÏ¿´À» ¶§ ¼ºÀûÀÌ ÁÁ´Ù´Â ±Ù°Å´Â ¾ø½À´Ï´Ù. ½ÇÁ¦ ÀÓ»ó¿¡¼­´Â È®´ëÀûÀÀÁõ Áß Àý´ëÀûÀÀÁõ¿¡ ¾ÆÁÖ °¡±î¿î °Íµé¸¸ ³»½Ã°æ Ä¡·á°¡ Àû¿ëµÇ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. µû¶ó¼­ 'Àý´ëÀûÀÀÁõ-like È®´ëÀûÀÀÁõ' Á¤µµ°¡ ÇöÀç °í·ÁÇÒ ¼ö ÀÖ´Â ³»½Ã°æ Ä¡·áÀÇ ÀûÀÀÁõÀÌ¶ó º¼ ¼ö ÀÖ½À´Ï´Ù. '±×³É È®´ëÀûÀÀÁõ'À» ³»½Ã°æ Ä¡·áÀÇ ÀûÀÀÁõÀ¸·Î º¸´Â °ÍÀº ³Ê¹« À§ÇèÇÑ ÀÏÀÔ´Ï´Ù. "

* Âü°í: EndoTODAY dignostic group classification before and after resection


[Selected oral presentations]

[UGI P-4] ¿¬¼¼´ëÇб³ °­³²¼¼ºê¶õ½º º´¿ø. Cheal Wung Huh.

À§ Á¾¾ç ³»½Ã°æÄ¡·á ÈÄ H. pylori Á¦±ÕÄ¡·á ½Ã early treatment (<2 ÁÖ)°¡ delayed treatment º¸´Ù Á¦±ÕÀ²ÀÌ ÁÁ¾Ò½À´Ï´Ù (early, 90.9%; intermediate, 76.2%; late, 72.4%; p<0.01).

[UGI 5] Ãáõ ÇѸ²´ëÇб³ Ãáõ º´¿ø. ¾ç¿µÁÖ

Non-Hp, non-NSAID peptic ulcer is an important etiology in the development of a peptic ulcer perforation, and smoking and alcohol consumption might be associated risk factors. Elderly women with comorbidities were associatd with NSAID-induced perforations.

[LGI P-1] °æºÏ´ëÇб³. ÀÌÇö¼®

Prophylatic endoscopic coagulation has an advantage in the prevention of overall postpolypectomy bleeding. However, it does not reduce the incidence of significant postpolypectomy bleeding.

[LGI P-2] ¼øõÇâ´ëÇб³. Á¤À±È£

ÀÌÁØÇà comment: Planned Hybrid ESD°¡ non-planned hybrid ESDº¸´Ù ¼ºÀûÀÌ ÁÁ¾Ò½À´Ï´Ù. Non-planned hybrid ESD´Â ½±°Ô ¸»Çϸé failed ESDÀÔ´Ï´Ù. µÎ ±×·ìÀÌ ³Ê¹« heterogeneousÇÕ´Ï´Ù. µû¶ó¼­ ÀÌ È¯ÀÚµéÀ» Á¦¿ÜÇÏ°í ºÐ¼®ÇÏ´Â °ÍÀÌ ´õ ÁÁÀ» °Í °°½À´Ï´Ù.

[LGI P-3] ÀÎõ¼º¸ðº´¿ø. ÁöÁ¤¼±

µé¾î°¥ ¶§ º¸¾Ò´ø ¿ëÁ¾À» ³ª¿Ã ¶§ ¸ø º¼ È®·üÀÌ 1.8%¶ó°í ÇÕ´Ï´Ù.

Inspection and polypectomy during both colonoscope insertion and withdrawal offered no additional advantage on the ADR (adenoma detection rate) compared to inspection and polypectomy performed during only withdrawal phase.

[UGI 31] ºÎ»êÀÇ´ë ±èÁß±Ù. ESD for EG junction neoplasm.

Hemisphere ±¸ºÐ

en bloc resection 96%, complete resection 77%, curative resection 71%À̾ú°í ulcerationÀÌ ÀÖ´Â °æ¿ì complete resection rate°¡ ³·¾Ò½À´Ï´Ù.

[UGI 33] ¿¬¼¼´ë °­³²¼¼ºê¶õ½º. ¸¶´ë¿ø. Electrocoagulation syndrome after esophageal ESD

Muscle layer exposure

2009³âºÎÅÍ 2016³â±îÁö esophageal ESD 55Áõ·Ê Áß frank perforation 4Áõ·Ê¸¦ Á¦¿ÜÇÑ 51Áõ·Ê Áß chest pain + fever/leukocytosis¿´´ø post-ESD electrocuagulation syndromeÀº 28 Áõ·Ê (54.9%) ¿´½À´Ï´Ù. 51¿¹ Áß procedure timeÀº 47.5ºÐ, SM invasionÀº 13¿¹ (25.5%)¿´½À´Ï´Ù. Post-ESD electrocuagulation syndromeÀÌ ¾ø¾ú´ø ȯÀÚ¿Í ÀÖ¾ú´ø ȯÀÚÀÇ muscle layer exposure°¡ °¢°¢ 30%, 54%¿´°í, resection area°¡ °¢°¢ 4.4, 6.5 cm2¿´½À´Ï´Ù.

[UGI 34] ¾ÆÁִ뺴¿ø ÀÓ¼±±³. Mitomycin C injection for refractory benign esophageal stenosis

MMC injection Àü Æò±Õ 8¹ø dilatation ¹ÞÀº ºÐµéÀ» ´ë»óÀ¸·Î MMC injectionÀ» 1ȸ (3¸í) ȤÀº 2ȸ (5¸í) ÇÏ¿´À» ¶§ 7¸íÀº ´Ü±âÀûÀ¸·Î´Â È£ÀüµÇ¾ú½À´Ï´Ù.

À±¿µÈÆ ±³¼ö´Ô Áú¹®: MMC´Â cotton soakingÀ» »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹Àºµ¥ soaking ´ë½Å injectionÀ» ÅÃÇÑ ÀÌÀ¯´Â ¹«¾ùÀ̾ú½À´Ï±î?

´äº¯: Á¼¾ÆÁø ºÎÀ§¿¡ Á¶½É½º·´°Ô ÁÖ»çÇÏ¸é »ý°¢º¸´Ù À§ÇèÇÏÁö ¾Ê°í Á¤»ó Á¡¸·Àº ¼Õ»óµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.

[UGI 38] ¼­¿ï´ë º¯¼±ÁÖ. Nationwide surveillance of additional gastrectomy after ESD for gastric malignancy of Korea

76.3% ¼ö¼ú (2014³â À§¾Ï ÀûÁ¤¼º Æò°¡ °á°ú º¸°í¼­)

½ÉÆò¿ø ÀڷḦ È°¿ëÇÏ¿© 2012³â 4¿ùºÎÅÍ 2014³â 12¿ù±îÁö ESD ÈÄ gastrectomy¸¦ ¹ÞÀº C16 ÄÚµåÀÇ È¯ÀÚ¸¦ ºÐ¼®

176°³ ÀÇ·á±â°üÀÇ 14,969¸í Áß 1,218¸í(8.1%)


[References]

1) ³»½Ã°æÇÐȸ ÇмúÇà»ç on-line Áß°è

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.